Intimation of receipt of letter from BSE dated 06 January 2026 and NSE dated 07 January 2026
SAILIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sai Life Sciences received warning letters from both BSE (dated 06 January 2026) and NSE (dated 07 January 2026) for not conducting any meeting of its Stakeholders' Relationship Committee (SRC) during the financial year 2024-25. This is a violation of SEBI LODR Regulation 20(3A), which requires the SRC to meet at least once a financial year. The company explained that its shares were listed only on 18 December 2024, leaving a short window until the fiscal year-end with no urgent matters requiring SRC attention. It had earlier provided this clarification to NSE on 21 May 2025. The company stated there is no material impact on its financial, operational, or other activities and reaffirmed its commitment to corporate governance standards.
This is a minor regulatory compliance warning with no financial or operational impact on the company. The lapse is explained by the short period between listing date and fiscal year-end, and the company has assured corrective measures. Investors should view it as a procedural governance note rather than a material risk, though repeated non-compliance could invite stricter regulatory action.